Key Takeaways
- Azuca’s Beyond Nano white paper offers a four-part framework focusing on consumer experience, product integrity, manufacturing performance, and product-specific evidence.
- It emphasizes the importance of a consistent manufacturing process for delivering fast-acting gummies that consumers want to repurchase.
- Azuca’s TiME INFUSION® technology uses molecular encapsulation, which preserves flavor and texture better than traditional nano-emulsions.
- The paper encourages brands to assess their products beyond just potency, considering shelf life and texture as key factors.
- Gummy manufacturers can use the Beyond Nano framework to evaluate infusion partners and ensure their product meets consumer expectations.
A fast-acting gummy has to earn a second purchase. The claim on the package can get someone interested, but great taste and a predictable experience give that person a reason to return. For the brand behind it, that experience depends on consistent manufacturing and product integrity throughout shelf life.
Cannabis has spent plenty of time selling consumers on numbers. THC percentage is the familiar example. In the infusion conversation, “nano” can become another shortcut: a technical description that sounds like a complete explanation of what someone is buying. A gummy manufacturer still needs to know what the ingredient will do inside the recipe and on the production line.
Azuca’s Beyond Nano white paper asks brands to evaluate that finished product more closely. Its framework covers four areas: consumer experience, product integrity across shelf life, manufacturing performance, and evidence in gummies. The companion paper, The Science of Fast-Acting, brings together the research behind the company’s approach.
This is a useful conversation for production managers and the people responsible for product marketing. A founder evaluating a new launch needs both perspectives. The promise made to the customer has to match what the operation can deliver, batch after batch, and an infusion specification is only one part of that decision.
What a Particle Size Claim Leaves Out
Beyond Nano challenges particle size as a substitute for evaluating an entire infusion process. As Azuca CEO and Co-Founder Kim Sanchez Rael puts it in the campaign announcement, “A delivery system has to prove itself in the recipe, on the production line and with the consumer.” That is a standard a buyer can put to work.
Gummies make the distinction tangible. In its paper, Azuca describes them as low-moisture, high-solids confections made through a heated, acidic process. Adding a water-based infusion near the end of the cook can change the moisture balance, creating additional work around drying and texture. How much adjustment is required depends on the ingredient and formulation.
Azuca’s TiME INFUSION® helps brands deliver fast-acting, predictable cannabinoid performance through a proprietary molecular encapsulation and infusion process. The process encapsulates individual cannabinoid molecules within structures with a water-friendly exterior, while conventional nano-emulsions suspend clusters of molecules in droplets.For gummy applications, the company says its approach avoids the emulsion interface and the surfactants needed to hold those droplets together. The stated aim is to preserve the confection’s intended flavor and manufacturing characteristics.
Start With the Experience People Pay For
The first test is whether people like the gummy itself. An emulsion that requires the team to compensate for unwanted flavor adds another formulation problem. Texture matters too: the chew should support the product the brand intended to make. Azuca’s framework pairs those sensory qualities with fast-acting, predictable performance to help brands build consumer trust.
The Beyond Nano materials describe an independent blind panel comparing a gummy powered by TiME INFUSION® with one made using a leading nano-emulsion. Azuca reports the products shared the same flavor and dose, with 73–78 respondents per measure. Participants assessed taste, texture, effects, overall liking, and purchase intent.
According to Azuca’s research summary, 86% rated the taste of the gummy made with its process good or very good, compared with 60% for the nano-emulsion product. The company reports higher ratings across all five measures. It also says 53% described the Azuca formulation’s effects as closer to smoking flower, compared with 36% for the alternative. Those findings describe the specific products tested; the effect comparison reflects participants’ reports.
For an operator, this is a reason to look past the ingredient presentation and test the confection people will actually eat. A blind comparison of the proposed recipe can reveal whether the infusion supports the flavor and chew that distinguish the brand. The panel results provide an example of finished-product evaluation, while each manufacturer still needs to establish the fit for its own launch.
Shelf Life Belongs in the Buying Decision
The second question extends the evaluation beyond launch day. Product integrity needs to hold from production through distribution and storage, and even in the back seat of the customer’s car. . Manufacturers need to understand what happens inside the final packaging over the storage period they intend to claim.
Beyond Nano asks buyers to look at potency retention alongside physical stability and texture. The paper identifies sweating, also called syneresis, and changes in chew as issues worth examining. Checking cannabinoid potency alone leaves part of the consumer experience unmeasured.
Azuca reports potency and stability at 12+ months in commercial gummy production. Its own qualification matters: those findings came from one recipe, in one package, from one manufacturer. They do not establish a universal shelf life for every product powered by TiME INFUSION®. Azuca encourages manufacturers to evaluate sampling timepoints, packaging, storage conditions, and the latest results to assess performance in their own finished products.
A manufacturer evaluating those results should ask about storage conditions and sampling timepoints, then establish what its own formulation requires. Texture deserves attention alongside the cannabinoid assay. The product that reaches a retailer after months in distribution needs to maintain the taste, texture, and dosing consistency the team approved at launch.
The Production Team Has to Make It Work
Manufacturing is the third part of the framework, and the people running the line need a place in the discussion before a purchasing decision is made. An ingredient’s quoted price cannot explain its full cost if implementation changes capacity or requires additional labor. Any effect on the production schedule belongs in the comparison.
Azuca describes its gummy infusion ingredient as arriving in a low-moisture form, with preparation using a benchtop mixer owned and operated by the partner. The company positions the TiME INFUSION® process around preserving existing formulations and allowing manufacturers to produce on their own schedule. That puts practical questions about implementation directly in front of the team responsible for running it.
The relevant comparison includes equipment requirements, the amount of process adjustment, and whether the facility can make what it needs when it needs it. Drying capacity deserves particular attention if it already limits output. An added step that appears modest in a demonstration can carry a different cost across repeated commercial batches.
For an established gummy brand, preserving the intended confection also protects prior development work. The team has already invested in getting its recipe right. A proposed infusion process should be evaluated against that baseline, with any necessary changes understood before the business commits to a wider rollout.
Evidence That Matches the Product
The fourth part of Beyond Nano asks buyers to examine evidence in their actual format. A result from a beverage or capsule does not establish how a gummy will perform. The Science of Fast-Acting complements the Beyond Nano framework with preclinical research, a human pharmacokinetic study, consumer reporting, and the blind comparison.
A human study led by Colorado State University researchers involved 20 participants comparing fast-acting, standard, and placebo edibles. According to Azuca’s research summaries reported in Cannabis and Cannabinoid Research, median time to peak blood THC concentration was 30 minutes for the gummy powered by TiME INFUSION®, compared with 60 minutes for the traditional edible. The abstract reported no significant differences between the two THC products in maximum concentration, terminal half-life, or total exposure measured by area under the curve.
That result supports an earlier blood-concentration peak under the study conditions. Timing matters to a brand developing a fast-acting product, while the experience a person reports remains a separate measure. An earlier peak does not promise an identical response for everyone.
Azuca also cites an ESEV preclinical pharmacokinetic study involving six animal subjects, reporting detection of Delta-9-THC in blood within 5–15 minutes. This contributes evidence about absorption in that model. It should be distinguished from a measured onset of effects in human consumers.
For the consumer perspective, the company summarizes a randomized real-world crossover study conducted through MoreBetter with 154 consumers, three products, and more than 2,000 daily reports. Azuca reports that 82% said the product powered by TiME INFUSION® took effect faster than the traditional edible, while 92% reported positive effects. The summary also says 85% would pay more, particularly with supporting research. Those are self-reported experiences and stated willingness to pay, rather than a forecast of sales for a new SKU.
The research is useful because it approaches the product from different directions. The human blood study and consumer reports compare against traditional edibles; the blind panel supplies the direct nano-emulsion comparison. Keeping those distinctions intact gives a brand a clearer basis for deciding which findings address its own questions.
Protecting the Product the Brand Has Built
Azuca is an applied bioscience company, and TiME INFUSION® is its biotech infusion platform. Its approach to gummies connects fast-acting, predictable performance with recipe integrity and manufacturing simplicity. The company emphasizes plant-derived inputs and a process that does not rely on synthetic surfactants.
That matters when different departments are evaluating the same launch. Product marketing needs evidence for what appears on the package. Operations need a workable manufacturing process. Leadership needs to understand the cost of implementation and the value the finished confection can offer. Beyond Nano gives those conversations a common set of questions.
The commercial case for Azuca rests on how its approach answers them: preserving great taste, supporting product integrity through storage, and enabling partner-controlled manufacturing. Those are specific propositions to evaluate with its team. They are also more useful to a buyer than assuming that a smaller particle settles the decision.
A Better Brief for the Next Gummy
A stronger product brief begins with the gummy the brand wants people to buy again. Define the intended experience and shelf-life requirements, then establish what the production line can accommodate. Ask the prospective infusion partner to explain how its process supports those goals and where validation is available.
For Beard Bros, the value of Beyond Nano is the focus it brings back to the people making and consuming cannabis products. The right infusion process helps manufacturers preserve their recipes and deliver predictable experiences that earn consumer trust and repeat purchase. The strongest story a brand can tell is one its formulation, manufacturing records, and customers’ experiences can support.
Download Beyond Nano and its companion, The Science of Fast-Acting, through Azuca’s campaign page at https://azuca.co/beyond-nano/. Gummy brands and manufacturers can use the framework to assess their next launch, review the supporting research, and connect with Azuca’s team through the same page to discuss their formulation and production requirements.
Sponsored content produced in partnership with Azuca®.
Frequently Asked Questions
Azuca’s Beyond Nano white paper challenges the industry’s reliance on particle size as a stand-in for evaluating a complete cannabis gummy infusion process. It offers a four-part framework covering consumer experience, shelf-life integrity, manufacturing performance, and product-specific evidence, giving brands a more complete way to assess an infusion partner before committing to a launch.
Azuca’s TiME INFUSION® technology uses molecular encapsulation rather than the emulsion-based approach common in conventional nano-emulsions. Instead of suspending clusters of molecules in droplets held together by surfactants, it encapsulates individual cannabinoid molecules within water-friendly structures, an approach the company says helps preserve a cannabis gummy’s intended flavor and texture.
Beyond Nano argues that product integrity has to hold up well beyond launch day, through distribution, storage, and the conditions a gummy actually experiences before it’s eaten. The paper points to potency retention, syneresis (sweating), and chew consistency as key markers, encouraging manufacturers to evaluate these factors for their own specific formulation and packaging rather than relying solely on potency testing.
Azuca’s companion paper, The Science of Fast-Acting, compiles a human pharmacokinetic study, a preclinical animal study, a real-world consumer crossover study, and an independent blind taste panel. Together, these sources examine absorption speed, consumer-reported effects, and head-to-head taste and texture comparisons against a leading nano-emulsion gummy.
Manufacturers can use Beyond Nano’s four areas, consumer experience, shelf-life integrity, manufacturing performance, and product-specific evidence, as a checklist when comparing infusion options. Beard Bros recommends defining the intended gummy experience and shelf-life requirements first, then asking a prospective partner like Azuca to show how its process supports those goals within an existing production line.
